Skip to main content
The Globe and Mail
Get full access to globeandmail.com
Support quality journalism
Just $1.99 per week for the first 24weeks
Just $1.99 per week for the first 24weeks
The Globe and Mail
Support quality journalism
Get full access to globeandmail.com
Globe and Mail website displayed on various devices
Just$1.99
per week
for the first 24weeks

var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){console.log("scroll");var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))}pencilInit(".js-sub-pencil",!1);
Cboe BZX Real-Time Last Sale USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 82.77
Day High 84.27
Open:83.70
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Global Anti-epileptic Drugs for Pediatrics Market 2020 - Industry Scenario, Strategies, Growth Factors and Forecast to 2025
- CDN Newswire - 35 minutes ago
CDN Newswire - CMTX
35 minutes ago
has announced a report titled which offers you more creative solutions that combine our in-depth geographic experience, intimate sector knowledge and clear insights into how to create value in your business. The report studies remarkable features of the global Anti-epileptic Drugs for Pediatrics industry such as market size, ongoing trends, drivers, risks, opportunities, and major segments. The report covers product specification, production analysis, and technology, product type, considering key features such as gross, gross margin, revenue & cost. Market research is based on historical information and present market requirements.
Global Acute Otitis Media Treatment Market 2020 - Industry Scenario, Strategies, Growth Factors and Forecast to 2025
- CDN Newswire - 37 minutes ago
CDN Newswire - CMTX
37 minutes ago
has added a new informative report titled as, to its storehouse which analyzes the market pricing trends, consumption trends and forecast sales between 2020 and 2025. The report examines the present status of the global Acute Otitis Media Treatment market and delivers projections on the future status of the market based on this investigation. The report contains an extensive analysis of the market, providing the data on the historical statistics from 2015 to 2019 and expected trends impacting the market during the period 2020 to 2025. The report delivers a critical evaluation of the industry by reasonably segmenting the market based on product type, component, application, and regions.
Proliferative Diabetic Retinopathy Market to Discern Magnified Growth During 2020-2026
- Market Prediction - Fri Apr 3, 7:38AM CDT
Market Prediction - CMTX
Fri Apr 3, 7:38AM CDT
In 2019, the global Proliferative Diabetic Retinopathy market size was million US$ and is forecast to million US in 2026, growing at a CAGR of from 2020. The objectives of this study are to define, segment, and project the size of the Proliferative Diabetic Retinopathy market based on company, product type, application and key regions.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 69.18 +20.90% increase
on 03/16/20
Period Open:83.62
Price movement based on the high, low and last over the given period.
87.87 -4.81% decrease
on 03/04/20
+0.02 (+0.02%) increase
since 03/03/20
3-Month 69.18 +20.90% increase
on 03/16/20
Period Open:94.79
Price movement based on the high, low and last over the given period.
99.84 -16.23% decrease
on 02/12/20
-11.15 (-11.76%) decrease
since 01/03/20
52-Week 69.18 +20.90% increase
on 03/16/20
Period Open:83.53
Price movement based on the high, low and last over the given period.
99.84 -16.23% decrease
on 02/12/20
+0.11 (+0.13%) increase
since 04/03/19

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2020.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies